These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15725472)

  • 61. Due to low infection rates no routine anti-infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine-based first line therapy.
    Eichhorst BF; Busch R; Schweighofer C; Wendtner CM; Emmerich B; Hallek M;
    Br J Haematol; 2007 Jan; 136(1):63-72. PubMed ID: 17083342
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemia.
    Foon KA; Boyiadzis M; Land SR; Marks S; Raptis A; Pietragallo L; Meisner D; Laman A; Sulecki M; Butchko A; Schaefer P; Lenzer D; Tarhini A
    J Clin Oncol; 2009 Feb; 27(4):498-503. PubMed ID: 19075274
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fludarabine: new indication. First-line treatment of CLL: unconvincing evidence.
    Prescrire Int; 2005 Feb; 14(75):3-5. PubMed ID: 15747447
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma to interdigitating dendritic cell sarcoma: evidence for transdifferentiation of the lymphoma clone.
    Fraser CR; Wang W; Gomez M; Zhang T; Mathew S; Furman RR; Knowles DM; Orazi A; Tam W
    Am J Clin Pathol; 2009 Dec; 132(6):928-39. PubMed ID: 19926586
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Metabolic response patterns of nucleotides in B-cell chronic lymphocytic leukaemias to cladribine, fludarabine and deoxycoformycin.
    Wilson PK; Mulligan SP; Christopherson RI
    Leuk Res; 2004 Jul; 28(7):725-31. PubMed ID: 15158094
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia.
    Lam CC; Ma ES; Kwong YL
    Am J Hematol; 2005 Aug; 79(4):288-90. PubMed ID: 16044456
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pre-treated patients with chronic lymphocytic leukemia.
    Laurenti L; Piccioni P; Tarnani M; De Padua L; Garzia M; Efremov DG; Piccirillo N; Chiusolo P; Sica S; Leone G
    Leuk Res; 2007 Feb; 31(2):253-6. PubMed ID: 16815546
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Richter's syndrome and acute transformation: two terminal haematological complications of chronic lymphoid leukaemia (author's transl)].
    Sebahoun G; Blanc AP; Sainty D; Gastaut JA; Carcassonne Y
    Sem Hop; 1980 Mar 8-15; 56(9-10):414-7. PubMed ID: 6244658
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fludarabine for chronic lymphocytic leukemia.
    Erman M; Celik I; Tekuzman G
    N Engl J Med; 2001 Apr; 344(15):1166; author reply 1167-8. PubMed ID: 11302142
    [No Abstract]   [Full Text] [Related]  

  • 70. Visceral varicella in a patient with chronic lymphocytic leukemia treated with fludarabine: a case report.
    Freedberg DE; Bhadelia N; Poneros JM; Oster MW
    Clin Lymphoma Myeloma Leuk; 2013 Feb; 13(1):90-2. PubMed ID: 23103084
    [No Abstract]   [Full Text] [Related]  

  • 71. Concomitant Epstein-Barr virus-negative large B-cell lymphoma (Richter syndrome) and Epstein-Barr virus- positive B-cell lymphoproliferation after treatment with fludarabine and cyclophosphamide in a patient with B-cell chronic lymphocytic leukemia.
    Compérat E; Delmer A; Le Tourneau A; Molina TJ; Diebold J; Audouin J
    Arch Pathol Lab Med; 2006 Aug; 130(8):1227-30. PubMed ID: 16879030
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.
    Dizdar O; Yürekli BS; Pürnak T; Aksu S; Haznedaroglu IC
    Ann Pharmacother; 2004; 38(7-8):1319-20. PubMed ID: 15138295
    [No Abstract]   [Full Text] [Related]  

  • 73. [Errors in the diagnosis and therapy of chronic lympholeukemias].
    Iakhnina EI; Astsaturov IA; Pivnik AV; Samoĭlova RS; Kremenetskaia AM; Vorob'ev AI
    Ter Arkh; 1995; 67(7):45-9. PubMed ID: 7482305
    [TBL] [Abstract][Full Text] [Related]  

  • 74. CLL progression after one cycle of FCR: Richter's transformation versus EBV-associated lympho-proliferation.
    Jain P; Burger JA; Khoury JD
    Am J Hematol; 2017 Oct; 92(10):1113-1114. PubMed ID: 28670739
    [No Abstract]   [Full Text] [Related]  

  • 75. Delayed response to fludarabine in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia.
    Del Giudice I; Matutes E; Osuji N; Parry-Jones N; Swansbury J; Catovsky D
    Haematologica; 2005 Feb; 90(2):268-70. PubMed ID: 15710588
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Hodgkin's disease variant of Richter's syndrome. Two cases and literature review].
    Dujardin F; Lefrancq T; Bléchet C; Boni-Boka M; Sénecal D; Desmoulins I; Guyétant S
    Ann Pathol; 2008 Sep; 28(4):311-6. PubMed ID: 18928873
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia.
    García-Barchino MJ; Sarasquete ME; Panizo C; Morscio J; Martinez A; Alcoceba M; Fresquet V; Gonzalez-Farre B; Paiva B; Young KH; Robles EF; Roa S; Celay J; Larrayoz M; Rossi D; Gaidano G; Montes-Moreno S; Piris MA; Balanzategui A; Jimenez C; Rodriguez I; Calasanz MJ; Larrayoz MJ; Segura V; Garcia-Muñoz R; Rabasa MP; Yi S; Li J; Zhang M; Xu-Monette ZY; Puig-Moron N; Orfao A; Böttcher S; Hernandez-Rivas JM; Miguel JS; Prosper F; Tousseyn T; Sagaert X; Gonzalez M; Martinez-Climent JA
    J Pathol; 2018 May; 245(1):61-73. PubMed ID: 29464716
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Epstein-Barr virus in patients with chronic lymphocytic leukemia: a pilot study.
    Tsimberidou AM; Keating MJ; Bueso-Ramos CE; Kurzrock R
    Leuk Lymphoma; 2006 May; 47(5):827-36. PubMed ID: 16753866
    [TBL] [Abstract][Full Text] [Related]  

  • 79. High molecular weight DNA fragmentation assay: a sensitive method for monitoring in vivo response to antileukemic chemotherapy.
    Badran A; Iwasaki H; Ueda T
    Anticancer Res; 2002; 22(5):3025-7. PubMed ID: 12530036
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cutaneous Richter syndrome: report of 3 cases from one institution.
    Yu L; Bandhlish A; Fullen DR; Su LD; Ma L
    J Am Acad Dermatol; 2012 Nov; 67(5):e187-93. PubMed ID: 21982061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.